225385-07-9

Basic information

• Product Name: 4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine
• Synonyms: 4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine
• CAS NO: 225385-07-9
• Molecular Formula: C13H9ClN2S
• Molecular Weight: 260.74196
• Mol File: 225385-07-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine(225385-07-9)
• EPA Substance Registry System: 4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine(225385-07-9)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 225385-07-9(Hazardous Substances Data)

Usage

General Description

4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine is a chemical compound with the molecular formula C13H9ClN2S. It is a thieno[3,2-d]pyrimidine derivative and is commonly used in the field of medicinal chemistry and drug research. 4-chloro-2-methyl-6-phenylthieno[3,2-d]pyrimidine has shown promising biological activities and has been studied for its potential as a therapeutic agent in the treatment of various diseases, including cancer and inflammatory disorders. Its unique chemical structure and properties make it a valuable target for further research and development in the pharmaceutical industry.

Upstream product

• 100063-22-7 methyl 3-amino-5-phenylthiophene-2-carboxylate 
• 156424-47-4 2-methyl-6-phenyl-thieno[3,2-d]pyrimidin-4-ol 

Relevant articles and documents

Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists

Neuropeptide Y (NPY) has been shown to play an important role in the regulation of food intake and energy balance. Pharmacological data suggests that the Y5 receptor subtype contributes to the effects of NPY on appetite, and therefore a Y5 antagonist might be a useful therapeutic agent for the treatment of obesity. In attempts to identify potential Y5 antagonists, a series of pyrrolo[3,2-d]pyrimidine derivatives was prepared and evaluated for their ability to bind to Y5 receptors in vitro. We report here the synthesis and initial structure-activity relationship investigations for this class of compounds. The target compounds were prepared by a variety of synthetic routes designed to modify both the substitution and the heterocyclic core of the pyrrolo[3,2-d]pyrimidine lead 1. In addition to identifying several potent Y5 antagonists for evaluation as potential antiobesity agents, a pharmacophore model for the human Y5 receptor is presented.